
Regional banking company Trustmark (NASDAQ:TRMK) met Wall Streets revenue expectations in Q4 CY2025, with sales up 3.7% year on year to $204.1 million. Its non-GAAP profit of $0.97 per share was 6.4% above analysts’ consensus estimates.
Is now the time to buy TRMK? Find out in our full research report (it’s free for active Edge members).
Trustmark’s fourth quarter results aligned with market expectations for revenue, with adjusted earnings per share outpacing analyst consensus. Management attributed the quarter’s performance to steady loan growth in its traditional banking segment, stronger profitability in mortgage banking, and record revenue in wealth management. CEO Duane Dewey highlighted that efforts to expand production talent and diversify the loan portfolio contributed to performance, while disciplined expense management and a cost-effective deposit base supported margins.
Looking ahead, Trustmark’s management expects mid-single-digit growth in both loans and deposits, supported by continued talent acquisition and potential market expansion. The company plans to maintain a disciplined approach to capital deployment, prioritizing organic loan growth but remaining open to selective mergers and acquisitions. CFO Tom Owens emphasized that loan growth and capital deployment will be the main levers affecting profitability, while expense management and investments in technology and production talent are expected to shape financial results in the coming year.
Management identified organic loan growth, effective cost control, and strong credit quality as the primary drivers of the quarter’s performance, while also noting improved profitability in mortgage and wealth management businesses.
Trustmark’s guidance for the next year centers on sustaining mid-single-digit growth in loans and deposits, while maintaining credit quality and managing expenses.
In the coming quarters, the StockStory team will monitor (1) the pace and breadth of loan and deposit growth resulting from new talent and market expansion, (2) sustained improvements in credit quality and stability in net charge-offs, and (3) the effectiveness of expense management as investments in technology and personnel continue. Updates on potential M&A activity and progress in noninterest income streams will also serve as important indicators of execution.
Trustmark currently trades at $41.41, in line with $41.14 just before the earnings. In the wake of this quarter, is it a buy or sell? See for yourself in our full research report (it’s free).
If your portfolio success hinges on just 4 stocks, your wealth is built on fragile ground. You have a small window to secure high-quality assets before the market widens and these prices disappear.
Don’t wait for the next volatility shock. Check out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
| Jul-29 | |
| Jul-29 | |
| Jul-28 | |
| Jul-28 | |
| Apr-29 | |
| Apr-28 | |
| Apr-28 | |
| Apr-14 | |
| Apr-01 | |
| Apr-01 | |
| Mar-09 | |
| Feb-19 | |
| Feb-05 | |
| Feb-03 | |
| Jan-29 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite